Diclofenac Potassium (Voltarol Rapid)
Is It Right for You?
A complete guide to Diclofenac Potassium (Voltarol Rapid) — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Diclofenac Potassium (Voltarol Rapid)?
Diclofenac potassium is a non-steroidal anti-inflammatory drug (NSAID) -- a class of medication that reduces pain, inflammation, and fever by blocking the production of prostaglandins, the chemical messengers responsible for driving the inflammatory response. It is one of the most widely prescribed NSAIDs in the world and is used across a broad range of acute and chronic painful conditions.
Diclofenac potassium is specifically formulated as an immediate-release preparation, which distinguishes it from diclofenac sodium formulations such as enteric-coated tablets and modified-release capsules. The potassium salt dissolves rapidly in the stomach, allowing faster absorption and a quicker onset of action -- typically within 15--30 minutes. This makes it particularly well suited to the treatment of acute pain where rapid relief is needed, such as migraine attacks, dental pain, renal colic, dysmenorrhoea, and acute musculoskeletal injuries.
Diclofenac potassium is available as tablets and is licensed for use in adults and adolescents over 14 years. It is available generically and under the brand name Voltarol Rapid, one of the most recognised NSAID brands in the UK.
Diclofenac potassium is a prescription-only medication in the UK at prescription strengths (50 mg). A licensed clinician must assess your symptoms and medical history before it can be prescribed -- which can now be done quickly and conveniently through a telehealth consultation.
What Conditions Is Diclofenac Potassium Used For?
Diclofenac potassium is used across a wide range of painful and inflammatory conditions where rapid onset of action is a priority:
sprains, strains, back pain, sports injuries, and soft tissue trauma; reduces both the pain and the inflammatory swelling associated with acute injury.
one of the most effective NSAIDs for primary dysmenorrhoea; prostaglandins drive uterine contractions and menstrual pain, and diclofenac's rapid onset makes it particularly useful started at the first sign of pain.
diclofenac potassium is a recognised treatment for acute migraine, with evidence supporting its effectiveness for both the headache and associated nausea; the rapid absorption of the potassium salt is particularly advantageous in this indication.
-
effective for the management of post-procedural and acute dental pain, reducing both the inflammatory and pain components.
pain caused by kidney stones passing through the ureter; diclofenac is a first-line analgesic for renal colic in emergency settings and is highly effective at reducing the intense spasmodic pain.
used as part of multimodal analgesia following surgical procedures.
Diclofenac has a higher cardiovascular risk profile than some other NSAIDs -- particularly ibuprofen and naproxen -- and should be used with caution or avoided entirely in patients with established cardiovascular disease, heart failure, recent heart attack, or stroke. It should always be used at the lowest effective dose for the shortest possible duration. A clinician will assess your cardiovascular risk before prescribing.
How Does Diclofenac Potassium Work?
Diclofenac is a non-selective cyclooxygenase (COX) inhibitor, meaning it inhibits both the COX-1 and COX-2 isoforms of the cyclooxygenase enzyme, though it has some preferential activity towards COX-2 compared to many other traditional NSAIDs.
The cyclooxygenase enzymes are responsible for converting arachidonic acid -- a fatty acid released from cell membranes in response to tissue damage or irritation -- into prostaglandins and thromboxanes. Prostaglandins are the key chemical mediators of inflammation: they sensitise pain receptors (nociceptors), cause vasodilation and increased vascular permeability (leading to swelling and redness), contribute to fever by acting on the hypothalamus, and stimulate uterine contractions (causing menstrual pain). By blocking COX enzymes, diclofenac reduces prostaglandin synthesis throughout the body, producing its analgesic, anti-inflammatory, and antipyretic effects.
COX-1 is constitutively expressed (always present) in many tissues and plays important protective roles -- including maintaining the gastric mucosal lining by stimulating protective prostaglandins, supporting platelet aggregation via thromboxane A2, and regulating renal blood flow. Inhibition of COX-1 is responsible for the gastrointestinal side effects, platelet inhibition, and renal effects associated with NSAID use.
COX-2 is inducible -- expressed primarily at sites of inflammation and injury -- and its inhibition is primarily responsible for the analgesic and anti-inflammatory effects of NSAIDs. It is also expressed in the cardiovascular system, where COX-2-derived prostacyclin (PGI2) acts as a vasodilator and platelet inhibitor. Preferential inhibition of COX-2 over COX-1 shifts the balance towards prothrombotic and vasoconstrictive effects, which is thought to underlie the cardiovascular risk associated with diclofenac and selective COX-2 inhibitors (coxibs).
The potassium salt formulation of diclofenac dissolves rapidly in gastric fluid, allowing faster absorption than the sodium salt enteric-coated formulations and achieving peak plasma concentrations within approximately 30--60 minutes.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Take diclofenac potassium with food or milk, or immediately after eating. Despite its rapid-release formulation, food helps protect the stomach lining and reduces the risk of gastrointestinal irritation, nausea, and dyspepsia. If taking it for migraine -- where speed of absorption is paramount -- it can be taken with a small amount of food if tolerated.
Take with a full glass of water and remain upright for at least 30 minutes after taking to reduce the risk of oesophageal irritation.
Use the lowest effective dose for the shortest possible time. NSAIDs including diclofenac carry dose-dependent risks for gastrointestinal, cardiovascular, and renal complications. The principle of minimum necessary dose and duration applies particularly strongly to diclofenac given its cardiovascular risk profile.
Do not take with other NSAIDs -- including over-the-counter ibuprofen or aspirin (at anti-inflammatory doses) -- as combining NSAIDs increases the risk of gastrointestinal bleeding without improving pain relief.
Consider gastroprotection. Patients taking diclofenac regularly, or those at increased risk of gastrointestinal complications (elderly patients, those with a history of ulcers, those on corticosteroids or anticoagulants), should discuss co-prescribing of a proton pump inhibitor (e.g. omeprazole) with their clinician.
Side Effects of Diclofenac Potassium
Diclofenac is generally well tolerated for short-term use in appropriate patients. The risk of both gastrointestinal and cardiovascular side effects increases with dose, duration of use, and in the presence of pre-existing risk factors.
- Nausea or stomach upset
- Abdominal pain or discomfort
- Dyspepsia (indigestion) and heartburn
- Diarrhoea or constipation
- Headache
- Dizziness
- Flatulence
- Elevated liver enzymes (usually asymptomatic and reversible)
Less Common Side Effects
- Fluid retention and oedema (ankle swelling)
- Raised blood pressure
- Skin rash
- Tinnitus (ringing in the ears)
- Drowsiness
- Gastrointestinal bleeding or perforation -- vomiting blood, black tarry stools, or sudden severe abdominal pain; can be life-threatening and may occur without prior warning symptoms, particularly in elderly patients
- Cardiovascular events -- myocardial infarction (heart attack), stroke, and heart failure; diclofenac carries a higher cardiovascular risk than naproxen or ibuprofen and comparable risk to selective COX-2 inhibitors; risk increases with dose and duration
- Severe liver toxicity -- hepatitis, liver failure; rare but reported; jaundice, dark urine, severe fatigue require immediate cessation and review
- Renal impairment / acute kidney injury -- particularly in patients who are dehydrated, elderly, or have pre-existing renal or cardiac disease
- Severe allergic reaction (anaphylaxis) -- urticaria, facial swelling, bronchospasm, and circulatory collapse; rare but requires immediate emergency treatment; more likely in patients with known aspirin or NSAID sensitivity
- Severe skin reactions -- Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis; very rare but potentially life-threatening
- Aseptic meningitis -- very rare; presents as headache, neck stiffness, and photophobia; more common in patients with autoimmune conditions
Approximately 10% of adults with asthma and a higher proportion of those with nasal polyps have aspirin- or NSAID-exacerbated respiratory disease (AERD), in which NSAIDs including diclofenac trigger bronchospasm and severe asthma attacks. Patients with asthma should use diclofenac with caution and must stop immediately and seek emergency care if they experience any worsening of breathing after taking it. A history of aspirin- or NSAID-triggered wheeze is a contraindication.
Drug Interactions
Diclofenac has a number of clinically important drug interactions. Always disclose all prescription drugs, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting diclofenac.
Diclofenac impairs platelet function and can cause gastrointestinal bleeding, while anticoagulants prevent clotting. This combination significantly increases the risk of serious and potentially fatal bleeding. The combination should generally be avoided; if unavoidable, it requires close clinical monitoring and gastroprotection.
Combining diclofenac with other NSAIDs provides no additional analgesic benefit and substantially increases the risk of gastrointestinal bleeding and adverse effects. This combination is contraindicated. Low-dose aspirin (75 mg) for cardiovascular protection may be continued but also increases GI bleeding risk.
NSAIDs antagonise the blood pressure-lowering effects of antihypertensives and diuretics, and the combination can cause acute kidney injury -- particularly in elderly or dehydrated patients (the "triple whammy" interaction: ACE inhibitor + diuretic + NSAID). Blood pressure and renal function should be monitored.
Diclofenac reduces the renal clearance of lithium, causing blood levels to rise and increasing the risk of lithium toxicity. Lithium levels should be monitored closely when starting or stopping diclofenac.
Important Warnings
Diclofenac has a higher cardiovascular risk profile than most other NSAIDs, including ibuprofen and naproxen. It is associated with an increased risk of myocardial infarction, stroke, and heart failure, particularly with prolonged use or at higher doses. This risk is comparable to that of selective COX-2 inhibitors (coxibs). Diclofenac is contraindicated in patients with established ischaemic heart disease, peripheral arterial disease, cerebrovascular disease, or heart failure. In patients with cardiovascular risk factors, the decision to prescribe must involve a careful assessment of individual risk and benefit.
Bleeding and Perforation All NSAIDs, including diclofenac, carry a risk of serious gastrointestinal events including ulceration, bleeding, and perforation of the stomach or intestine. These events can occur without warning symptoms at any point during treatment -- not only at the start. Elderly patients, those with a history of peptic ulcer disease, those on anticoagulants or corticosteroids, and those who smoke or consume alcohol regularly are at highest risk. Gastroprotection with a PPI should be co-prescribed in at-risk patients.
Diclofenac has a higher rate of liver enzyme elevation than many other NSAIDs. Clinically significant hepatotoxicity, including severe hepatitis and liver failure, has been reported, albeit rarely. Liver function should be monitored in patients on prolonged courses, and diclofenac should be avoided in patients with significant hepatic impairment. Symptoms of liver toxicity -- jaundice, dark urine, right upper abdominal pain -- require immediate cessation of treatment and medical review.
Diclofenac is contraindicated in patients with a history of bronchospasm, urticaria, or rhinitis triggered by aspirin or other NSAIDs. In asthmatic patients without known NSAID sensitivity, diclofenac should be used with caution. Worsening of asthma during NSAID treatment requires immediate cessation and medical review.
Diclofenac is contraindicated from 20 weeks of pregnancy onwards due to the risk of foetal renal dysfunction, oligohydramnios (reduced amniotic fluid), and premature closure of the ductus arteriosus (a critical foetal blood vessel), which can cause serious and potentially fatal complications. It should be used with caution and only if absolutely necessary in the first and second trimesters. Diclofenac passes into breast milk in small amounts; short-term use at low doses is generally considered acceptable during breastfeeding but should be discussed with your clinician.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Diclofenac Potassium FAQs
Yes. A licensed clinician can assess your symptoms, medical history, and cardiovascular and gastrointestinal risk factors via a telehealth consultation and prescribe diclofenac potassium if clinically appropriate. Given its cardiovascular risk profile, a thorough assessment is important. Prescriptions are typically sent to your preferred pharmacy the same day.
Thanks to the rapid dissolution of the potassium salt, diclofenac potassium typically begins to relieve pain within 15--30 minutes of ingestion, with peak effect around 1--2 hours after taking. This rapid onset distinguishes it from enteric-coated diclofenac sodium tablets, which can take 2--3 hours to reach peak levels.
Topical diclofenac -- available as gels (e.g. Voltarol Emulgel) and medicated plasters -- is an effective alternative for localised musculoskeletal pain such as soft tissue injuries and osteoarthritis of accessible joints. Topical formulations deliver the drug directly to the site of pain with significantly lower systemic absorption than oral tablets, substantially reducing the risk of gastrointestinal, cardiovascular, and renal side effects. For conditions amenable to topical treatment, this is often the preferred approach -- particularly in patients with cardiovascular or gastrointestinal risk factors. Oral diclofenac is necessary for systemic conditions such as migraine, dysmenorrhoea, or widespread inflammatory arthritis.
Yes. Diclofenac and paracetamol work through different mechanisms and can be safely combined for additional pain relief -- this is a common and recommended approach in multimodal analgesia. Do not combine diclofenac with other NSAIDs (such as ibuprofen or naproxen), as this provides no additional benefit and significantly increases the risk of side effects.
With caution. Approximately 10% of asthmatic adults have aspirin- or NSAID-exacerbated respiratory disease (AERD), in which NSAIDs trigger bronchospasm. If you have asthma but have previously taken ibuprofen or other NSAIDs without breathing problems, you are unlikely to have AERD. If you have never taken an NSAID before, your clinician will assess the risk. If you experience any worsening of breathing, wheezing, or chest tightness after taking diclofenac, stop immediately and seek emergency care.
Diclofenac is contraindicated in patients with established ischaemic heart disease, peripheral arterial disease, cerebrovascular disease (including prior stroke or TIA), or heart failure. If you have any of these conditions, diclofenac should not be prescribed. Naproxen is generally considered to have a more favourable cardiovascular safety profile among NSAIDs and may be a more appropriate alternative, though all NSAIDs carry some cardiovascular risk. Always inform your clinician of your full cardiac history before any NSAID is prescribed.
Many patients benefit from co-prescribing of a proton pump inhibitor (such as omeprazole 20 mg daily) alongside diclofenac to reduce the risk of gastrointestinal ulceration and bleeding. This is particularly important for patients who are elderly, have a history of peptic ulcer disease, are also taking corticosteroids, anticoagulants, or SSRIs, or who smoke or drink alcohol regularly. Your clinician will assess whether gastroprotection is appropriate for you.